Home ➤ Life Science ➤ Healthcare ➤ Drug Discovery Services Market
Drug Discovery Services Market
Published date: March 2025 • Formats:
Request Sample Schedule a Call

Drug Discovery Services Market By Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation), By Type (Chemistry Services and Biology Services), By Drug Type (Small Molecule Drugs and Biologics Drug), By Therapeutic Area (Oncology, Neurological Diseases, Cardiovascular Diseases, Respiratory Diseases, Digestive System Diseases and Others), By End-User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories and Academic and Research Institutes), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: March 2025
  • Report ID: 140781
  • Number of Pages: 358
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Drug Discovery Services Market Trends
      • 2.3. Regulatory Framework
      • 2.4. Opportunity Map Analysis
      • 2.5. Opportunity Orbits
      • 2.6. PESTLE Analysis
      • 2.7. PORTER’S Five Force Analysis
      • 2.8. Drivers & Restraints Impact Analysis
      • 2.9. Value Chain Analysis
        • 2.9.1. List of Raw Materials Suppliers
        • 2.9.2. List of Drug Discovery Services Manufacturers
        • 2.9.3. List of Dealer/Distributors
      • 2.10. Regional Market Share and BPS Analysis
      • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Drug Discovery Services Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Process, 2020-2034
      • 3.3. Global Drug Discovery Services Market Attractiveness Analysis, By Process
        • 3.3.1. Target Selection
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Target Validation
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Hit-To-LeadIdentification
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
        • 3.3.4. Lead Optimization
          • 3.3.4.1. Insights
          • 3.3.4.2. Key Takeaways
        • 3.3.5. Candidate Validation
          • 3.3.5.1. Insights
          • 3.3.5.2. Key Takeaways
      • 3.4. Global Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 3.5. Global Drug Discovery Services Market Attractiveness Analysis, By Type
        • 3.5.1. Chemistry Services
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Biology Services
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
      • 3.6. Global Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Drug Type, 2020-2034
      • 3.7. Global Drug Discovery Services Market Attractiveness Analysis, By Drug Type
        • 3.7.1. Small Molecule Drugs
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Biologics Drug
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
      • 3.8. Global Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2020-2034
      • 3.9. Global Drug Discovery Services Market Attractiveness Analysis, By Therapeutic Area
        • 3.9.1. Oncology
          • 3.9.1.1. Insights
          • 3.9.1.2. Key Takeaways
        • 3.9.2. Neurological Diseases
          • 3.9.2.1. Insights
          • 3.9.2.2. Key Takeaways
        • 3.9.3. Cardiovascular Diseases
          • 3.9.3.1. Insights
          • 3.9.3.2. Key Takeaways
        • 3.9.4. Respiratory Diseases
          • 3.9.4.1. Insights
          • 3.9.4.2. Key Takeaways
        • 3.9.5. Digestive System Diseases
          • 3.9.5.1. Insights
          • 3.9.5.2. Key Takeaways
        • 3.9.6. Others
          • 3.9.6.1. Insights
          • 3.9.6.2. Key Takeaways
      • 3.10. Global Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 3.11. Global Drug Discovery Services Market Attractiveness Analysis, By End-User
        • 3.11.1. Pharmaceutical and Biotechnology Companies
          • 3.11.1.1. Insights
          • 3.11.1.2. Key Takeaways
        • 3.11.2. Clinical Laboratories
          • 3.11.2.1. Insights
          • 3.11.2.2. Key Takeaways
        • 3.11.3. Academic and Research Institutes
          • 3.11.3.1. Insights
          • 3.11.3.2. Key Takeaways
    • 4. Global Drug Discovery Services Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Drug Discovery Services Market Attractiveness Analysis, By Region
    • 5. North America Drug Discovery Services Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Process, 2020-2034
      • 5.3. North America Drug Discovery Services Market Attractiveness Analysis, By Process
      • 5.4. North America Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 5.5. North America Drug Discovery Services Market Attractiveness Analysis, By Type
      • 5.6. North America Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Drug Type, 2020-2034
      • 5.7. North America Drug Discovery Services Market Attractiveness Analysis, By Drug Type
      • 5.8. North America Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2020-2034
      • 5.9. North America Drug Discovery Services Market Attractiveness Analysis, By Therapeutic Area
      • 5.10. North America Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 5.11. North America Drug Discovery Services Market Attractiveness Analysis, By End-User
      • 5.12. North America Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.13. North America Drug Discovery Services Market Attractiveness Analysis, By Country
        • 5.13.1. The US
        • 5.13.2. Canada
    • 6. Europe Drug Discovery Services Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Process, 2020-2034
      • 6.3. Europe Drug Discovery Services Market Attractiveness Analysis, By Process
      • 6.4. Europe Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 6.5. Europe Drug Discovery Services Market Attractiveness Analysis, By Type
      • 6.6. Europe Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Drug Type, 2020-2034
      • 6.7. Europe Drug Discovery Services Market Attractiveness Analysis, By Drug Type
      • 6.8. Europe Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2020-2034
      • 6.9. Europe Drug Discovery Services Market Attractiveness Analysis, By Therapeutic Area
      • 6.10. Europe Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 6.11. Europe Drug Discovery Services Market Attractiveness Analysis, By End-User
      • 6.12. Europe Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.13. Europe Drug Discovery Services Market Attractiveness Analysis, By Country
        • 6.13.1. Germany
        • 6.13.2. The UK
        • 6.13.3. France
        • 6.13.4. Spain
        • 6.13.5. Italy
        • 6.13.6. Russia
        • 6.13.7. Netherland
        • 6.13.8. Rest of Europe
    • 7. Asia Pacific Drug Discovery Services Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Process, 2020-2034
      • 7.3. Asia Pacific Drug Discovery Services Market Attractiveness Analysis, By Process
      • 7.4. Asia Pacific Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 7.5. Asia Pacific Drug Discovery Services Market Attractiveness Analysis, By Type
      • 7.6. Asia Pacific Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Drug Type, 2020-2034
      • 7.7. Asia Pacific Drug Discovery Services Market Attractiveness Analysis, By Drug Type
      • 7.8. Asia Pacific Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2020-2034
      • 7.9. Asia Pacific Drug Discovery Services Market Attractiveness Analysis, By Therapeutic Area
      • 7.10. Asia Pacific Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 7.11. Asia Pacific Drug Discovery Services Market Attractiveness Analysis, By End-User
      • 7.12. Asia Pacific Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.13. Asia Pacific Drug Discovery Services Market Attractiveness Analysis, By Country
        • 7.13.1. China
        • 7.13.2. Japan
        • 7.13.3. South Korea
        • 7.13.4. India
        • 7.13.5. Australia
        • 7.13.6. New Zealand
        • 7.13.7. Singapore
        • 7.13.8. Thailand
        • 7.13.9. Vietnam
        • 7.13.10. Rest of Asia Pacific
    • 8. Latin America Drug Discovery Services Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Process, 2020-2034
      • 8.3. Latin America Drug Discovery Services Market Attractiveness Analysis, By Process
      • 8.4. Latin America Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 8.5. Latin America Drug Discovery Services Market Attractiveness Analysis, By Type
      • 8.6. Latin America Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Drug Type, 2020-2034
      • 8.7. Latin America Drug Discovery Services Market Attractiveness Analysis, By Drug Type
      • 8.8. Latin America Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2020-2034
      • 8.9. Latin America Drug Discovery Services Market Attractiveness Analysis, By Therapeutic Area
      • 8.10. Latin America Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 8.11. Latin America Drug Discovery Services Market Attractiveness Analysis, By End-User
      • 8.12. Latin America Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.13. Latin America Drug Discovery Services Market Attractiveness Analysis, By Country
        • 8.13.1. Brazil
        • 8.13.2. Mexico
        • 8.13.3. Rest of Latin America
    • 9. Middle East & Africa Drug Discovery Services Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Process, 2020-2034
      • 9.3. Middle East & Africa Drug Discovery Services Market Attractiveness Analysis, By Process
      • 9.4. Middle East & Africa Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 9.5. Middle East & Africa Drug Discovery Services Market Attractiveness Analysis, By Type
      • 9.6. Middle East & Africa Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Drug Type, 2020-2034
      • 9.7. Middle East & Africa Drug Discovery Services Market Attractiveness Analysis, By Drug Type
      • 9.8. Middle East & Africa Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2020-2034
      • 9.9. Middle East & Africa Drug Discovery Services Market Attractiveness Analysis, By Therapeutic Area
      • 9.10. Middle East & Africa Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 9.11. Middle East & Africa Drug Discovery Services Market Attractiveness Analysis, By End-User
      • 9.12. Middle East & Africa Drug Discovery Services Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.13. Middle East & Africa Drug Discovery Services Market Attractiveness Analysis, By Country
        • 9.13.1. South Africa
        • 9.13.2. Saudi Arabia
        • 9.13.3. UAE
        • 9.13.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. Thermo Fisher Scientific Inc.
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. EVOTEC SE
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Laboratory Corporation of America Holdings
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. WuXi AppTec Co., Ltd.
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Charles River Laboratories
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Dalton Pharma Services
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Eurofins Discovery
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Syngene International Limited
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
        • 10.7.9. GenScript ProBio
          • 10.7.9.1. Company Details
          • 10.7.9.2. Business Overview
          • 10.7.9.3. Product Portfolio
          • 10.7.9.4. Financial Insights
          • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.9.6. SWOT Analysis
          • 10.7.9.7. Geographic Footprint
        • 10.7.10. Domainex Ltd.
          • 10.7.10.1. Company Details
          • 10.7.10.2. Business Overview
          • 10.7.10.3. Product Portfolio
          • 10.7.10.4. Financial Insights
          • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.10.6. SWOT Analysis
          • 10.7.10.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 2. Global Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 3. Global Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 4. Global Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 5. Global Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 6. Global Drug Discovery Services Market Value (US$ Bn), By Region, 2020-2034
      • Table 7. North America Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 8. North America Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 9. North America Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 10. North America Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 11. North America Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 12. North America Drug Discovery Services Market Value (US$ Bn), By Country, 2020-2034
      • Table 13. The US Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 14. The US Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 15. The US Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 16. The US Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 17. The US Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 18. Canada Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 19. Canada Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 20. Canada Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 21. Canada Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 22. Canada Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 23. Europe Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 24. Europe Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 25. Europe Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 26. Europe Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 27. Europe Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 28. Europe Drug Discovery Services Market Value (US$ Bn), By Country, 2020-2034
      • Table 29. Germany Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 30. Germany Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 31. Germany Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 32. Germany Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 33. Germany Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 34. The UK Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 35. The UK Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 36. The UK Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 37. The UK Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 38. The UK Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 39. France Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 40. France Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 41. France Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 42. France Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 43. France Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 44. Spain Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 45. Spain Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 46. Spain Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 47. Spain Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 48. Spain Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 49. Italy Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 50. Italy Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 51. Italy Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 52. Italy Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 53. Italy Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 54. Russia Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 55. Russia Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 56. Russia Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 57. Russia Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 58. Russia Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 59. Netherland Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 60. Netherland Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 61. Netherland Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 62. Netherland Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 63. Netherland Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 64. Rest of Europe Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 65. Rest of Europe Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 66. Rest of Europe Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 67. Rest of Europe Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 68. Rest of Europe Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 69. Asia Pacific Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 70. Asia Pacific Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 71. Asia Pacific Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 72. Asia Pacific Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 73. Asia Pacific Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 74. Asia Pacific Drug Discovery Services Market Value (US$ Bn), By Country, 2020-2034
      • Table 75. China Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 76. China Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 77. China Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 78. China Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 79. China Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 80. India Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 81. India Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 82. India Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 83. India Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 84. India Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 85. Japan Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 86. Japan Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 87. Japan Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 88. Japan Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 89. Japan Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 90. South Korea Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 91. South Korea Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 92. South Korea Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 93. South Korea Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 94. South Korea Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 95. Australia Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 96. Australia Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 97. Australia Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 98. Australia Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 99. Australia Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 100. New Zealand Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 101. New Zealand Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 102. New Zealand Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 103. New Zealand Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 104. New Zealand Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 105. Singapore Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 106. Singapore Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 107. Singapore Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 108. Singapore Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 109. Singapore Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 110. Thailand Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 111. Thailand Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 112. Thailand Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 113. Thailand Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 114. Thailand Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 115. Vietnam Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 116. Vietnam Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 117. Vietnam Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 118. Vietnam Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 119. Vietnam Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 120. Rest of Asia Pacific Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 121. Rest of Asia Pacific Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 122. Rest of Asia Pacific Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 123. Rest of Asia Pacific Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 124. Rest of Asia Pacific Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 125. Latin America Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 126. Latin America Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 127. Latin America Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 128. Latin America Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 129. Latin America Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 130. Latin America Drug Discovery Services Market Value (US$ Bn), By Country, 2020-2034
      • Table 131. Brazil Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 132. Brazil Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 133. Brazil Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 134. Brazil Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 135. Brazil Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 136. Mexico Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 137. Mexico Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 138. Mexico Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 139. Mexico Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 140. Mexico Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 141. Rest of Latin America Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 142. Rest of Latin America Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 143. Rest of Latin America Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 144. Rest of Latin America Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 145. Rest of Latin America Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 146. Middle East & Africa Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 147. Middle East & Africa Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 148. Middle East & Africa Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 149. Middle East & Africa Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 150. Middle East & Africa Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 151. Middle East & Africa Drug Discovery Services Market Value (US$ Bn), By Country, 2020-2034
      • Table 152. South Africa Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 153. South Africa Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 154. South Africa Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 155. South Africa Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 156. South Africa Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 157. Saudi Arabia Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 158. Saudi Arabia Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 159. Saudi Arabia Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 160. Saudi Arabia Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 161. Saudi Arabia Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 162. UAE Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 163. UAE Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 164. UAE Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 165. UAE Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 166. UAE Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
      • Table 167. Rest of Middle East & Africa Drug Discovery Services Market Value (US$ Bn), By Process, 2020-2034
      • Table 168. Rest of Middle East & Africa Drug Discovery Services Market Value (US$ Bn), By Type, 2020-2034
      • Table 169. Rest of Middle East & Africa Drug Discovery Services Market Value (US$ Bn), By Drug Type, 2020-2034
      • Table 170. Rest of Middle East & Africa Drug Discovery Services Market Value (US$ Bn), By Therapeutic Area, 2020-2034
      • Table 171. Rest of Middle East & Africa Drug Discovery Services Market Value (US$ Bn), By End-User, 2020-2034
    • List of Figures
      • Figure 1. Global Drug Discovery Services Market Snapshot: Market Value (US$ Bn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Drug Discovery Services Market
      • Figure 5. Global Drug Discovery Services Market Analysis, By Process, 2020, 2024 and 2034
      • Figure 6. Global Drug Discovery Services Market Attractiveness Analysis, By Process
      • Figure 7. Global Drug Discovery Services Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 8. Global Drug Discovery Services Market Attractiveness Analysis, By Type
      • Figure 9. Global Drug Discovery Services Market Analysis, By Drug Type, 2020, 2024 and 2034
      • Figure 10. Global Drug Discovery Services Market Attractiveness Analysis, By Drug Type
      • Figure 11. Global Drug Discovery Services Market Analysis, By Therapeutic Area, 2020, 2024 and 2034
      • Figure 12. Global Drug Discovery Services Market Attractiveness Analysis, By Therapeutic Area
      • Figure 13. Global Drug Discovery Services Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 14. Global Drug Discovery Services Market Attractiveness Analysis, By End-User
      • Figure 15. Global Drug Discovery Services Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 16. Global Drug Discovery Services Market Attractiveness Analysis, By Region
      • Figure 17. North America Drug Discovery Services Market Analysis, By Process, 2020, 2024 and 2034
      • Figure 18. North America Drug Discovery Services Market Attractiveness Analysis, By Process
      • Figure 19. North America Drug Discovery Services Market (US$ Bn), by Target Selection, 2020-2034
      • Figure 20. North America Drug Discovery Services Market (US$ Bn), by Target Validation, 2020-2034
      • Figure 21. North America Drug Discovery Services Market (US$ Bn), by Hit-To-LeadIdentification, 2020-2034
      • Figure 22. North America Drug Discovery Services Market (US$ Bn), by Lead Optimization, 2020-2034
      • Figure 23. North America Drug Discovery Services Market (US$ Bn), by Candidate Validation, 2020-2034
      • Figure 24. North America Drug Discovery Services Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 25. North America Drug Discovery Services Market Attractiveness Analysis, By Type
      • Figure 26. North America Drug Discovery Services Market (US$ Bn), by Chemistry Services, 2020-2034
      • Figure 27. North America Drug Discovery Services Market (US$ Bn), by Biology Services, 2020-2034
      • Figure 28. North America Drug Discovery Services Market Analysis, By Drug Type, 2020, 2024 and 2034
      • Figure 29. North America Drug Discovery Services Market Attractiveness Analysis, By Drug Type
      • Figure 30. North America Drug Discovery Services Market (US$ Bn), by Small Molecule Drugs, 2020-2034
      • Figure 31. North America Drug Discovery Services Market (US$ Bn), by Biologics Drug, 2020-2034
      • Figure 32. North America Drug Discovery Services Market Analysis, By Therapeutic Area, 2020, 2024 and 2034
      • Figure 33. North America Drug Discovery Services Market Attractiveness Analysis, By Therapeutic Area
      • Figure 34. North America Drug Discovery Services Market (US$ Bn), by Oncology, 2020-2034
      • Figure 35. North America Drug Discovery Services Market (US$ Bn), by Neurological Diseases, 2020-2034
      • Figure 36. North America Drug Discovery Services Market (US$ Bn), by Cardiovascular Diseases, 2020-2034
      • Figure 37. North America Drug Discovery Services Market (US$ Bn), by Respiratory Diseases, 2020-2034
      • Figure 38. North America Drug Discovery Services Market (US$ Bn), by Digestive System Diseases, 2020-2034
      • Figure 39. North America Drug Discovery Services Market (US$ Bn), by Others, 2020-2034
      • Figure 40. North America Drug Discovery Services Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 41. North America Drug Discovery Services Market Attractiveness Analysis, By End-User
      • Figure 42. North America Drug Discovery Services Market (US$ Bn), by Pharmaceutical and Biotechnology Companies, 2020-2034
      • Figure 43. North America Drug Discovery Services Market (US$ Bn), by Clinical Laboratories, 2020-2034
      • Figure 44. North America Drug Discovery Services Market (US$ Bn), by Academic and Research Institutes, 2020-2034
      • Figure 45. North America Drug Discovery Services Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 46. North America Drug Discovery Services Market Attractiveness Analysis, By Country
      • Figure 47. Europe Drug Discovery Services Market Analysis, By Process, 2020, 2024 and 2034
      • Figure 48. Europe Drug Discovery Services Market Attractiveness Analysis, By Process
      • Figure 49. Europe Drug Discovery Services Market (US$ Bn), by Target Selection, 2020-2034
      • Figure 50. Europe Drug Discovery Services Market (US$ Bn), by Target Validation, 2020-2034
      • Figure 51. Europe Drug Discovery Services Market (US$ Bn), by Hit-To-LeadIdentification, 2020-2034
      • Figure 52. Europe Drug Discovery Services Market (US$ Bn), by Lead Optimization, 2020-2034
      • Figure 53. Europe Drug Discovery Services Market (US$ Bn), by Candidate Validation, 2020-2034
      • Figure 54. Europe Drug Discovery Services Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 55. Europe Drug Discovery Services Market Attractiveness Analysis, By Type
      • Figure 56. Europe Drug Discovery Services Market (US$ Bn), by Chemistry Services, 2020-2034
      • Figure 57. Europe Drug Discovery Services Market (US$ Bn), by Biology Services, 2020-2034
      • Figure 58. Europe Drug Discovery Services Market Analysis, By Drug Type, 2020, 2024 and 2034
      • Figure 59. Europe Drug Discovery Services Market Attractiveness Analysis, By Drug Type
      • Figure 60. Europe Drug Discovery Services Market (US$ Bn), by Small Molecule Drugs, 2020-2034
      • Figure 61. Europe Drug Discovery Services Market (US$ Bn), by Biologics Drug, 2020-2034
      • Figure 62. Europe Drug Discovery Services Market Analysis, By Therapeutic Area, 2020, 2024 and 2034
      • Figure 63. Europe Drug Discovery Services Market Attractiveness Analysis, By Therapeutic Area
      • Figure 64. Europe Drug Discovery Services Market (US$ Bn), by Oncology, 2020-2034
      • Figure 65. Europe Drug Discovery Services Market (US$ Bn), by Neurological Diseases, 2020-2034
      • Figure 66. Europe Drug Discovery Services Market (US$ Bn), by Cardiovascular Diseases, 2020-2034
      • Figure 67. Europe Drug Discovery Services Market (US$ Bn), by Respiratory Diseases, 2020-2034
      • Figure 68. Europe Drug Discovery Services Market (US$ Bn), by Digestive System Diseases, 2020-2034
      • Figure 69. Europe Drug Discovery Services Market (US$ Bn), by Others, 2020-2034
      • Figure 70. Europe Drug Discovery Services Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 71. Europe Drug Discovery Services Market Attractiveness Analysis, By End-User
      • Figure 72. Europe Drug Discovery Services Market (US$ Bn), by Pharmaceutical and Biotechnology Companies, 2020-2034
      • Figure 73. Europe Drug Discovery Services Market (US$ Bn), by Clinical Laboratories, 2020-2034
      • Figure 74. Europe Drug Discovery Services Market (US$ Bn), by Academic and Research Institutes, 2020-2034
      • Figure 75. Europe Drug Discovery Services Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 76. Europe Drug Discovery Services Market Attractiveness Analysis, By Country
      • Figure 77. Asia Pacific Drug Discovery Services Market Analysis, By Process, 2020, 2024 and 2034
      • Figure 78. Asia Pacific Drug Discovery Services Market Attractiveness Analysis, By Process
      • Figure 79. Asia Pacific Drug Discovery Services Market (US$ Bn), by Target Selection, 2020-2034
      • Figure 80. Asia Pacific Drug Discovery Services Market (US$ Bn), by Target Validation, 2020-2034
      • Figure 81. Asia Pacific Drug Discovery Services Market (US$ Bn), by Hit-To-LeadIdentification, 2020-2034
      • Figure 82. Asia Pacific Drug Discovery Services Market (US$ Bn), by Lead Optimization, 2020-2034
      • Figure 83. Asia Pacific Drug Discovery Services Market (US$ Bn), by Candidate Validation, 2020-2034
      • Figure 84. Asia Pacific Drug Discovery Services Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 85. Asia Pacific Drug Discovery Services Market Attractiveness Analysis, By Type
      • Figure 86. Asia Pacific Drug Discovery Services Market (US$ Bn), by Chemistry Services, 2020-2034
      • Figure 87. Asia Pacific Drug Discovery Services Market (US$ Bn), by Biology Services, 2020-2034
      • Figure 88. Asia Pacific Drug Discovery Services Market Analysis, By Drug Type, 2020, 2024 and 2034
      • Figure 89. Asia Pacific Drug Discovery Services Market Attractiveness Analysis, By Drug Type
      • Figure 90. Asia Pacific Drug Discovery Services Market (US$ Bn), by Small Molecule Drugs, 2020-2034
      • Figure 91. Asia Pacific Drug Discovery Services Market (US$ Bn), by Biologics Drug, 2020-2034
      • Figure 92. Asia Pacific Drug Discovery Services Market Analysis, By Therapeutic Area, 2020, 2024 and 2034
      • Figure 93. Asia Pacific Drug Discovery Services Market Attractiveness Analysis, By Therapeutic Area
      • Figure 94. Asia Pacific Drug Discovery Services Market (US$ Bn), by Oncology, 2020-2034
      • Figure 95. Asia Pacific Drug Discovery Services Market (US$ Bn), by Neurological Diseases, 2020-2034
      • Figure 96. Asia Pacific Drug Discovery Services Market (US$ Bn), by Cardiovascular Diseases, 2020-2034
      • Figure 97. Asia Pacific Drug Discovery Services Market (US$ Bn), by Respiratory Diseases, 2020-2034
      • Figure 98. Asia Pacific Drug Discovery Services Market (US$ Bn), by Digestive System Diseases, 2020-2034
      • Figure 99. Asia Pacific Drug Discovery Services Market (US$ Bn), by Others, 2020-2034
      • Figure 100. Asia Pacific Drug Discovery Services Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 101. Asia Pacific Drug Discovery Services Market Attractiveness Analysis, By End-User
      • Figure 102. Asia Pacific Drug Discovery Services Market (US$ Bn), by Pharmaceutical and Biotechnology Companies, 2020-2034
      • Figure 103. Asia Pacific Drug Discovery Services Market (US$ Bn), by Clinical Laboratories, 2020-2034
      • Figure 104. Asia Pacific Drug Discovery Services Market (US$ Bn), by Academic and Research Institutes, 2020-2034
      • Figure 105. Asia Pacific Drug Discovery Services Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 106. Asia Pacific Drug Discovery Services Market Attractiveness Analysis, By Country
      • Figure 107. Latin America Drug Discovery Services Market Analysis, By Process, 2020, 2024 and 2034
      • Figure 108. Latin America Drug Discovery Services Market Attractiveness Analysis, By Process
      • Figure 109. Latin America Drug Discovery Services Market (US$ Bn), by Target Selection, 2020-2034
      • Figure 110. Latin America Drug Discovery Services Market (US$ Bn), by Target Validation, 2020-2034
      • Figure 111. Latin America Drug Discovery Services Market (US$ Bn), by Hit-To-LeadIdentification, 2020-2034
      • Figure 112. Latin America Drug Discovery Services Market (US$ Bn), by Lead Optimization, 2020-2034
      • Figure 113. Latin America Drug Discovery Services Market (US$ Bn), by Candidate Validation, 2020-2034
      • Figure 114. Latin America Drug Discovery Services Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 115. Latin America Drug Discovery Services Market Attractiveness Analysis, By Type
      • Figure 116. Latin America Drug Discovery Services Market (US$ Bn), by Chemistry Services, 2020-2034
      • Figure 117. Latin America Drug Discovery Services Market (US$ Bn), by Biology Services, 2020-2034
      • Figure 118. Latin America Drug Discovery Services Market Analysis, By Drug Type, 2020, 2024 and 2034
      • Figure 119. Latin America Drug Discovery Services Market Attractiveness Analysis, By Drug Type
      • Figure 120. Latin America Drug Discovery Services Market (US$ Bn), by Small Molecule Drugs, 2020-2034
      • Figure 121. Latin America Drug Discovery Services Market (US$ Bn), by Biologics Drug, 2020-2034
      • Figure 122. Latin America Drug Discovery Services Market Analysis, By Therapeutic Area, 2020, 2024 and 2034
      • Figure 123. Latin America Drug Discovery Services Market Attractiveness Analysis, By Therapeutic Area
      • Figure 124. Latin America Drug Discovery Services Market (US$ Bn), by Oncology, 2020-2034
      • Figure 125. Latin America Drug Discovery Services Market (US$ Bn), by Neurological Diseases, 2020-2034
      • Figure 126. Latin America Drug Discovery Services Market (US$ Bn), by Cardiovascular Diseases, 2020-2034
      • Figure 127. Latin America Drug Discovery Services Market (US$ Bn), by Respiratory Diseases, 2020-2034
      • Figure 128. Latin America Drug Discovery Services Market (US$ Bn), by Digestive System Diseases, 2020-2034
      • Figure 129. Latin America Drug Discovery Services Market (US$ Bn), by Others, 2020-2034
      • Figure 130. Latin America Drug Discovery Services Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 131. Latin America Drug Discovery Services Market Attractiveness Analysis, By End-User
      • Figure 132. Latin America Drug Discovery Services Market (US$ Bn), by Pharmaceutical and Biotechnology Companies, 2020-2034
      • Figure 133. Latin America Drug Discovery Services Market (US$ Bn), by Clinical Laboratories, 2020-2034
      • Figure 134. Latin America Drug Discovery Services Market (US$ Bn), by Academic and Research Institutes, 2020-2034
      • Figure 135. Latin America Drug Discovery Services Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 136. Latin America Drug Discovery Services Market Attractiveness Analysis, By Country
      • Figure 137. Middle East and Africa Drug Discovery Services Market Analysis, By Process, 2020, 2024 and 2034
      • Figure 138. Middle East and Africa Drug Discovery Services Market Attractiveness Analysis, By Process
      • Figure 139. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Target Selection, 2020-2034
      • Figure 140. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Target Validation, 2020-2034
      • Figure 141. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Hit-To-LeadIdentification, 2020-2034
      • Figure 142. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Lead Optimization, 2020-2034
      • Figure 143. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Candidate Validation, 2020-2034
      • Figure 144. Middle East and Africa Drug Discovery Services Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 145. Middle East and Africa Drug Discovery Services Market Attractiveness Analysis, By Type
      • Figure 146. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Chemistry Services, 2020-2034
      • Figure 147. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Biology Services, 2020-2034
      • Figure 148. Middle East and Africa Drug Discovery Services Market Analysis, By Drug Type, 2020, 2024 and 2034
      • Figure 149. Middle East and Africa Drug Discovery Services Market Attractiveness Analysis, By Drug Type
      • Figure 150. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Small Molecule Drugs, 2020-2034
      • Figure 151. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Biologics Drug, 2020-2034
      • Figure 152. Middle East and Africa Drug Discovery Services Market Analysis, By Therapeutic Area, 2020, 2024 and 2034
      • Figure 153. Middle East and Africa Drug Discovery Services Market Attractiveness Analysis, By Therapeutic Area
      • Figure 154. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Oncology, 2020-2034
      • Figure 155. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Neurological Diseases, 2020-2034
      • Figure 156. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Cardiovascular Diseases, 2020-2034
      • Figure 157. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Respiratory Diseases, 2020-2034
      • Figure 158. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Digestive System Diseases, 2020-2034
      • Figure 159. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Others, 2020-2034
      • Figure 160. Middle East and Africa Drug Discovery Services Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 161. Middle East and Africa Drug Discovery Services Market Attractiveness Analysis, By End-User
      • Figure 162. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Pharmaceutical and Biotechnology Companies, 2020-2034
      • Figure 163. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Clinical Laboratories, 2020-2034
      • Figure 164. Middle East and Africa Drug Discovery Services Market (US$ Bn), by Academic and Research Institutes, 2020-2034
      • Figure 165. Middle East and Africa Drug Discovery Services Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 166. Middle East and Africa Drug Discovery Services Market Attractiveness Analysis, By Country
    • Thermo Fisher Scientific Company Profile
    • EVOTEC SE
    • Laboratory Corporation of America Holdings
    • WuXi AppTec Co., Ltd.
    • Charles River Laboratories
    • Dalton Pharma Services
    • Eurofins Discovery
    • Syngene International Limited
    • GenScript ProBio
    • Domainex Ltd.
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Drug Discovery Services Market
  • 140781
  • March 2025
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options